CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,086 enrolled
Drug / intervention
non-interventional retrospective epidemiological observational studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04172467
NCT04172467N/ACompleted
CompareCT.gov

Quality Assurance on Diagnosis and Therapy of Secondary Immunodeficiencies (SID) in Patients With Chronic Lymphocytic Leukemia (CLL) or Multiple Myeloma (MM) in Germany (QS-SID)

AIO-Studien-gGmbH·observational·Posted Nov 21, 2019·Updated Jan 10, 2022

In Brief

An observational study evaluating non-interventional retrospective epidemiological observational study for Secondary Immunodeficiencies (SID). Completed, enrolled 1,086 participants across 1 site.

Detailed Summary

Retrospective, representative registry for quality assurance on diagnosis and therapy of secondary immunodeficiencies (SID) in patients with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM)

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSecondary Immunodeficiencies (SID)
CountriesGermany
CollaboratorsProf. Hartmut Link, Takeda, MMF GmbH, AIO AG Supportivtherapie, AG Supportive Maßnahmen in der Onkologie

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 21, 2019
Enrollment StartJan 28, 2020
Primary CompletionApr 25, 2020
Study CompletionAug 3, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.6 years ago

Interventions

non-interventional retrospective epidemiological observational studyother

non-interventional retrospective epidemiological observational study